Mark Robert Albertella

Suggest Changes
Learn More
PURPOSE The antitumor activities and pharmacokinetics of the hypoxia-activated cytotoxin AQ4N and its metabolites were assessed in several preclinical models of pancreatic cancers. EXPERIMENTAL(More)